FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

AvKARE Pitavastatin Tablets Recall

Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, P…

AvKARE · Pulaski, TN

Risk level
Class III
Reported by FDA
Jul 9, 2025
Recall ID
D-0529-2025
Check your lot numberHow we source this data

Summary

AvKARE recalled Pitavastatin Tablets starting Jun 26, 2025. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0529-2025 on Jul 9, 2025. Reason: Failed Impurity/Degradation Specifications. Status: Ongoing.

Why it was recalled

Failed Impurity/Degradation Specifications

Product description

Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906-90

Lot numbers, UPCs & expiration codes

Lot, expiry: Lot 46211, exp 10/31/2025; Lot 47683, exp 05/31/2026; Lot 46944 , exp 01/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0529-2025
Classification
Class III
Status
Ongoing
Recall initiated
Jun 26, 2025
FDA report date
Jul 9, 2025
Quantity
8,573 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
AvKARE

Original FDA data

Every field from FDA enforcement report D-0529-2025, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Ongoing
Country
United States
Event ID
97160
Address
615 N 1st St
Code information
Lot, expiry: Lot 46211, exp 10/31/2025; Lot 47683, exp 05/31/2026; Lot 46944 , exp 01/31/2026
Postal code
38478-2403
Report date
Jul 9, 2025
Product type
Drugs
Recall number
D-0529-2025
Classification
Class III
Recalling firm
AvKARE
Product quantity
8,573 bottles
Reason for recall
Failed Impurity/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906-90
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 26, 2025
Initial firm notification
Letter
Center classification date
Jul 16, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0529-2025, published Jul 9, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls